Scientists have called out GlaxoSmithKline’s diabetes drug Avandia as unsafe for patients because they say it increases the risk of heart attacks. But on Monday, an FDA advisory panel recommended that the drug stay on the market. What gives?
Original post by Kristen Philipkoski
0 Responses to “FDA Drug Standards: What's Safe Enough?”